In human embryonic stem cells, knocking out RB1 gene by CRISPR/Cas9 would lead to the formation of neural enriched teratomas, which mimic the trilateral retinoblastoma tumors (Avior et al., 2017). The gene discussed is RB1; the disease is retinoblastoma.